Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 1/20 | 0.35 |
| ▸ | FABP3 | P05413 | 1/20 | 0.35 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.32 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.32 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.32 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1372811 | 0.79 | GAA (0.46) | — | |
| SCHEMBL30517279 | 0.79 | GAA (0.46) | — | |
| SCHEMBL6678412 | 0.77 | ENPP2 (0.44) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL29706601 | 0.77 | ENPP2 (0.44) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL3842879 | 0.75 | POLB (0.39) | FABP7FABP3FABP5EZH2PTGDR2 | |
| SCHEMBL28539601 | 0.72 | ADRA2B (0.33) | FABP7FABP3FABP5 | |
| SCHEMBL29993703 | 0.71 | CA1 (0.55) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL2885055 | 0.71 | LMNA (0.42) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL236305 | 0.71 | CA1 (0.55) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL10519027 | 0.71 | FFAR1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118974043-A | Polq inhibitor compounds and uses thereof | 南京再明医药有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118525025-A | Six-membered cyclothiazole compound and application thereof | 南京再明医药有限公司 | 2024-08-20 | — | — | CN | disclosed |